Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2006 (Vol. 26, No. 20)

The Astrochymist

URL:www.astrochymist.org
  • Creativity in design
  • Narrow audience
One of my dreams as a child was to become an astronaut, and while today I think the value of humans in space is overrated, I still carry a fascination with the findings of astronomers and the various robot spacecraft we have out there. It was a particular pleasure, therefore, to discover “The Astrochymist” (no, that’s not a typo) site, which is packed with resources for astrochemists and interested bystanders. The designer(s) of the site have put a lot of thought into it. Start with the astromolecule of the month. Move from there to the most intelligently designed FAQ I’ve ever seen on a website. Describing the FAQ won’t do—you’ve got to see it to appreciate it. Other highlights include a Who’s Who in astrochemistry, an updated publications list, conference info, links, and a news archive. Kudos to the designer(s).
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »